Sfoglia per Autore
Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients
2023-01-01 D'Agostino, Mattia; Bertuglia, Giuseppe; Rota-Scalabrini, Delia; Belotti, Angelo; Morè, Sonia; Corradini, Paolo; Oliva, Stefania; Ledda, Antonio; Grasso, Mariella; Pavone, Vincenzo; Ronconi, Sonia; Vincelli, Iolanda Donatella; Ballanti, Stelvio; Velluti, Cristina; Cellini, Claudia; Gozzetti, Alessandro; Palmas, Angelo D; Gamberi, Barbara; Mancuso, Katia; Paris, Laura; Zambello, Renato; Petrucci, Maria Teresa; Bruno, Benedetto; Musto, Pellegrino; Gay, Francesca
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing
2023-01-01 Oliva, Stefania; Genuardi, Elisa; Paris, Laura; D'Agostino, Mattia; Rogers, Jennifer; Rota-Scalabrini, Delia; Jacob, Allison P; Patriarca, Francesca; Luppi, Mario; Bertazzoni, Paola; Velluti, Cristina; Capra, Andrea; Saraci, Elona; Rossi, Marco; Allegra, Alessandro; Mina, Roberto; Gentile, Massimo; Kirsch, Ilan R; Belotti, Angelo; Cavo, Michele; Bruno, Benedetto; Musto, Pellegrino; Boccadoro, Mario; Zamagni, Elena; Gay, Francesca
Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop
2023-01-01 Terpos E.; Neri P.; van de Donk N.W.C.J.; D'Agostino M.; Parekh S.; Jagannath S.; Ludwig H.; Avigan D.E.; Dhodapkar M.V.; Raje N.S.
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial
2023-01-01 Zamagni, Elena; Oliva, Stefania; Gay, Francesca; Capra, Andrea; Rota-Scalabrini, Delia; D'Agostino, Mattia; Belotti, Angelo; Galli, Monica; Racca, Manuela; Zambello, Renato; Gamberi, Barbara; Albano, Domenico; Bertamini, Luca; Versari, Annibale; Grasso, Mariella; Sgherza, Nicola; Priola, Claudia; Fioritoni, Francesca; Patriarca, Francesca; De Cicco, Gabriella; Villanova, Tania; Pascarella, Anna; Zucchetta, Pietro; Tacchetti, Paola; Fanti, Stefano; Mancuso, Katia; Barbato, Simona; Boccadoro, Mario; Musto, Pellegrino; Cavo, Michele; Nanni, Cristina
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma
2023-01-01 Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Labrador, Maria; Maccagno, Monica; Cumerlato, Michela; Oreglia, Federico; Prever, Lorenzo; Manicardi, Veronica; Taiana, Elisa; Ronchetti, Domenica; D'Agostino, Mattia; Gay, Francesca; Larocca, Alessandra; Besse, Lenka; Merlo, Giorgio Roberto; Hirsch, Emilio; Ciarrocchi, Alessia; Inghirami, Giorgio; Neri, Antonino; Piva, Roberto
Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?
2023-01-01 D'Agostino, Mattia; Terragna, Carolina; van Duin, Mark
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status
2022-01-01 Giannotta, Claudia; Castella, Barbara; Tripoli, Ezio; Grimaldi, Daniele; Avonto, Ilaria; D’Agostino, Mattia; Larocca, Alessandra; Kopecka, Joanna; Grasso, Mariella; Riganti, Chiara; Massaia, Massimo
IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA
2022-01-01 C Giannotta, B Castella, E Tripoli, C Riganti, IC Salaroglio, M D'Agostino, M Massaia.
Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting
2022-01-01 Bonello F.; Cani L.; D'Agostino M.
Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?
2022-01-01 Bertuglia, Giuseppe; Cani, Lorenzo; Larocca, Alessandra; Gay, Francesca; D'Agostino, Mattia
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
2022-01-01 D'Agostino, Mattia; Cairns, David A; Lahuerta, Juan José; Wester, Ruth; Bertsch, Uta; Waage, Anders; Zamagni, Elena; Mateos, María-Victoria; Dall'Olio, Daniele; van de Donk, Niels W C J; Jackson, Graham; Rocchi, Serena; Salwender, Hans; Bladé Creixenti, Joan; van der Holt, Bronno; Castellani, Gastone; Bonello, Francesca; Capra, Andrea; Mai, Elias K; Dürig, Jan; Gay, Francesca; Zweegman, Sonja; Cavo, Michele; Kaiser, Martin F; Goldschmidt, Hartmut; Hernández Rivas, Jesús María; Larocca, Alessandra; Cook, Gordon; San-Miguel, Jesús F; Boccadoro, Mario; Sonneveld, Pieter
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma
2021-01-01 Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study
2021-01-01 Rizzello I.; Cavo M.; Dozza L.; Rivolti E.; Petrucci M.T.; De Stefano V.; Antonioli E.; Tosi P.; D'Agostino M.; More S.; Gozzetti A.; Cea M.; Barbato S.; Tacchetti P.; Pantani L.; Mancuso K.; Rocchi S.; De Cicco G.; Fusco A.; Zamagni E.
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
2021-01-01 Bruno, Benedetto; Wäsch, Ralph; Engelhardt, Monika; Gay, Francesca; Giaccone, Luisa; D'Agostino, Mattia; Rodríguez-Lobato, Luis-Gerardo; Danhof, Sophia; Gagelmann, Nico; Kröger, Nicolaus; Popat, Rakesh; Van de Donk, Niels W C J; Terpos, Evangelos; Dimopoulos, Meletios A; Sonneveld, Pieter; Einsele, Hermann; Boccadoro, Mario
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma
2021-01-01 Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P.
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score
2021-01-01 D'Agostino M.; Larocca A.; Offidani M.; Liberati A.M.; Gaidano G.; Petrucci M.T.; Derudas D.; Capra A.; Zambello R.; Cascavilla N.; de Fabritiis P.; Innao V.; Bonello F.; Patriarca F.; Benevolo G.; Giuliani N.; Aitoro G.; Guglielmelli T.; Di Raimondo F.; Corradini P.; Musto P.; Hajek R.; Sonneveld P.; Boccadoro M.; Bringhen S.
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial
2021-01-01 Oliva, Stefania; Hofste op Bruinink, Davine; Rihova, Lucie; D'Agostino, Mattia; Pantani, Lucia; Capra, Andrea; van der Holt, Bronno; Troia, Rossella; Petrucci, Maria Teresa; Villanova, Tania; Vsianska, Pavla; Jugooa, Romana; Brandt-Hagens, Claudia; Gilestro, Milena; Offidani, Massimo; Ribolla, Rossella; Galli, Monica; Hajek, Roman; Gay, Francesca; Cavo, Michele; Omedé, Paola; van der Velden, Vincent H J; Boccadoro, Mario; Sonneveld, Pieter
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial
2021-01-01 Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Nicola; de Fabritiis, Paolo; Aquino, Sara; Palmas, Angelo; Gamberi, Barbara; Zambello, Renato; Petrucci, Maria Teresa; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario
MRD Assessment in Multiple Myeloma: Progress and Challenges
2021-01-01 Bertamini L.; D'Agostino M.; Gay F.
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma
2021-01-01 Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients | 2023 | D'Agostino, Mattia; Bertuglia, Giuseppe; Rota-Scalabrini, Delia; Belotti, Angelo; Morè, Sonia; Corradini, Paolo; Oliva, Stefania; Ledda, Antonio; Grasso, Mariella; Pavone, Vincenzo; Ronconi, Sonia; Vincelli, Iolanda Donatella; Ballanti, Stelvio; Velluti, Cristina; Cellini, Claudia; Gozzetti, Alessandro; Palmas, Angelo D; Gamberi, Barbara; Mancuso, Katia; Paris, Laura; Zambello, Renato; Petrucci, Maria Teresa; Bruno, Benedetto; Musto, Pellegrino; Gay, Francesca | |
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing | 2023 | Oliva, Stefania; Genuardi, Elisa; Paris, Laura; D'Agostino, Mattia; Rogers, Jennifer; Rota-Scalabrini, Delia; Jacob, Allison P; Patriarca, Francesca; Luppi, Mario; Bertazzoni, Paola; Velluti, Cristina; Capra, Andrea; Saraci, Elona; Rossi, Marco; Allegra, Alessandro; Mina, Roberto; Gentile, Massimo; Kirsch, Ilan R; Belotti, Angelo; Cavo, Michele; Bruno, Benedetto; Musto, Pellegrino; Boccadoro, Mario; Zamagni, Elena; Gay, Francesca | |
Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop | 2023 | Terpos E.; Neri P.; van de Donk N.W.C.J.; D'Agostino M.; Parekh S.; Jagannath S.; Ludwig H.; Avigan D.E.; Dhodapkar M.V.; Raje N.S. | |
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial | 2023 | Zamagni, Elena; Oliva, Stefania; Gay, Francesca; Capra, Andrea; Rota-Scalabrini, Delia; D'Agostino, Mattia; Belotti, Angelo; Galli, Monica; Racca, Manuela; Zambello, Renato; Gamberi, Barbara; Albano, Domenico; Bertamini, Luca; Versari, Annibale; Grasso, Mariella; Sgherza, Nicola; Priola, Claudia; Fioritoni, Francesca; Patriarca, Francesca; De Cicco, Gabriella; Villanova, Tania; Pascarella, Anna; Zucchetta, Pietro; Tacchetti, Paola; Fanti, Stefano; Mancuso, Katia; Barbato, Simona; Boccadoro, Mario; Musto, Pellegrino; Cavo, Michele; Nanni, Cristina | |
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma | 2023 | Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Labrador, Maria; Maccagno, Monica; Cumerlato, Michela; Oreglia, Federico; Prever, Lorenzo; Manicardi, Veronica; Taiana, Elisa; Ronchetti, Domenica; D'Agostino, Mattia; Gay, Francesca; Larocca, Alessandra; Besse, Lenka; Merlo, Giorgio Roberto; Hirsch, Emilio; Ciarrocchi, Alessia; Inghirami, Giorgio; Neri, Antonino; Piva, Roberto | |
Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment? | 2023 | D'Agostino, Mattia; Terragna, Carolina; van Duin, Mark | |
Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status | 2022 | Giannotta, Claudia; Castella, Barbara; Tripoli, Ezio; Grimaldi, Daniele; Avonto, Ilaria; D’Agostino, Mattia; Larocca, Alessandra; Kopecka, Joanna; Grasso, Mariella; Riganti, Chiara; Massaia, Massimo | |
IMMUNE SUPPRESSION OF BONE MARROW Vγ9Vδ2 T CELLS BY BONE MARROW STROMAL CELLS (BMSC) IN MULTIPLE MYELOMA | 2022 | C Giannotta, B Castella, E Tripoli, C Riganti, IC Salaroglio, M D'Agostino, M Massaia. | |
Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting | 2022 | Bonello F.; Cani L.; D'Agostino M. | |
Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma? | 2022 | Bertuglia, Giuseppe; Cani, Lorenzo; Larocca, Alessandra; Gay, Francesca; D'Agostino, Mattia | |
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project | 2022 | D'Agostino, Mattia; Cairns, David A; Lahuerta, Juan José; Wester, Ruth; Bertsch, Uta; Waage, Anders; Zamagni, Elena; Mateos, María-Victoria; Dall'Olio, Daniele; van de Donk, Niels W C J; Jackson, Graham; Rocchi, Serena; Salwender, Hans; Bladé Creixenti, Joan; van der Holt, Bronno; Castellani, Gastone; Bonello, Francesca; Capra, Andrea; Mai, Elias K; Dürig, Jan; Gay, Francesca; Zweegman, Sonja; Cavo, Michele; Kaiser, Martin F; Goldschmidt, Hartmut; Hernández Rivas, Jesús María; Larocca, Alessandra; Cook, Gordon; San-Miguel, Jesús F; Boccadoro, Mario; Sonneveld, Pieter | |
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma | 2021 | Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara | |
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study | 2021 | Rizzello I.; Cavo M.; Dozza L.; Rivolti E.; Petrucci M.T.; De Stefano V.; Antonioli E.; Tosi P.; D'Agostino M.; More S.; Gozzetti A.; Cea M.; Barbato S.; Tacchetti P.; Pantani L.; Mancuso K.; Rocchi S.; De Cicco G.; Fusco A.; Zamagni E. | |
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma | 2021 | Bruno, Benedetto; Wäsch, Ralph; Engelhardt, Monika; Gay, Francesca; Giaccone, Luisa; D'Agostino, Mattia; Rodríguez-Lobato, Luis-Gerardo; Danhof, Sophia; Gagelmann, Nico; Kröger, Nicolaus; Popat, Rakesh; Van de Donk, Niels W C J; Terpos, Evangelos; Dimopoulos, Meletios A; Sonneveld, Pieter; Einsele, Hermann; Boccadoro, Mario | |
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma | 2021 | Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P. | |
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score | 2021 | D'Agostino M.; Larocca A.; Offidani M.; Liberati A.M.; Gaidano G.; Petrucci M.T.; Derudas D.; Capra A.; Zambello R.; Cascavilla N.; de Fabritiis P.; Innao V.; Bonello F.; Patriarca F.; Benevolo G.; Giuliani N.; Aitoro G.; Guglielmelli T.; Di Raimondo F.; Corradini P.; Musto P.; Hajek R.; Sonneveld P.; Boccadoro M.; Bringhen S. | |
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial | 2021 | Oliva, Stefania; Hofste op Bruinink, Davine; Rihova, Lucie; D'Agostino, Mattia; Pantani, Lucia; Capra, Andrea; van der Holt, Bronno; Troia, Rossella; Petrucci, Maria Teresa; Villanova, Tania; Vsianska, Pavla; Jugooa, Romana; Brandt-Hagens, Claudia; Gilestro, Milena; Offidani, Massimo; Ribolla, Rossella; Galli, Monica; Hajek, Roman; Gay, Francesca; Cavo, Michele; Omedé, Paola; van der Velden, Vincent H J; Boccadoro, Mario; Sonneveld, Pieter | |
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial | 2021 | Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Nicola; de Fabritiis, Paolo; Aquino, Sara; Palmas, Angelo; Gamberi, Barbara; Zambello, Renato; Petrucci, Maria Teresa; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario | |
MRD Assessment in Multiple Myeloma: Progress and Challenges | 2021 | Bertamini L.; D'Agostino M.; Gay F. | |
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma | 2021 | Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile